LRP4 and myasthenia gravis: Indeed, studies in Chinese populations suggested that LRP4 antibodies are less frequent than in Western countries, as they were only found in 1–2.9% of SNMG and 0.8–1.7% of the total MG patients, while they were associated mostly with OMG (73, 79).